Bariatric Surgery and Procedures
o coronary artery disease o lower extremity lymphatic or venous obstruction o obstructive sleep apnea o pulmonary hypertension o evidence of fatty liver disease (i.e., nonalcoholic fatty liver disease [NAFLD] or nonalcoholic steatohepatitis [NASH]) o gastroesophageal reflux disease (GERD) refractory to medical therapy
Download Bariatric Surgery and Procedures
Information
Domain:
Source:
Link to this page:
Documents from same domain
Molecular Diagnostic Testing for Hematology and Oncology ...
static.cigna.comGeneral Criteria for Somatic Mutation Genetic Testing ... initiate a related therapy and the therapy has been validated by the National Comprehensive Cancer Network™ (NCCN Guidelines™) as a category 1, 2A, or 2B recommendation for the ... Detection of circulating whole tumor cells for any other indication is considered experimental,
Anesthesia Services for Interventional Pain Management ...
static.cigna.comMonitored anesthesia care (MAC) is a service rendered by an anesthesia practitioner (i.e., anesthesiologist, certified registered nurse anesthetist CRNA]) who is not involved in the diagnostic or procedural service being performed. The ASA defines MAC as
REVENUE CODE LIST-CPT-HCPCS - Cigna
static.cigna.comREVENUE CODE LIST-CPT-HCPCS For Providers Effective March 15, 2020 . All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, includingCigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Cigna Behavioral Health, Inc., and HMO or service
Minimally Invasive Spine Surgery Procedures and Trigger ...
static.cigna.comTrigger Point: Trigger point injection therapy involves the injection of anesthetic or corticosteroids into distinct, focal hyper-irritable spots (i.e., trigger points) located in a tight band of skeletal muscle. Myofascial pain syndrome is a chronic form of muscle pain centered near trigger points.
Diabetes Equipment and Supplies
static.cigna.com• hypoglycemic wristband alarm (e.g., Diabetes Sentry™) External Insulin Pumps . ANY of the following external insulin pumps * is considered medically necessary for the management of type 1 and type 2 diabetes mellitus: • an external insulin pump* (HCPCS code E0784) including a combined or integrated continuous
Welcome to Cigna Behavioral Health
static.cigna.comThe practitioner has thirty (30) days from the receipt of the suspension or termination letter to make a written request for reconsideration. Cigna Behavioral Health's Credentialing Committee Appeal Panel will review the appeal at its next monthly meeting and issue a written notification of the outcome to the practitioner.
Speech Therapy - Cigna
static.cigna.comspeech-language pathologist for a significant voice disorder associated with the laryngeal structures that are associated with anatomic abnormality, neurological condition, injury (e.g., vocal nodules or polyps, vocal cord paresis or paralysis, paradoxical vocal …
Nucleic Acid Pathogen Testing - Cigna
static.cigna.como human papillomavirus (HPV) cervical cancer screening • Symptomatic individuals when the associated signs and symptoms or diagnoses, are listed in the ... Chlamydial infection is the most frequently reported infectious disease in the United States (IDSA, 2018; CDC,
Transcranial Magnetic Stimulation
static.cigna.comTranscranial Magnetic Stimulation (TMS) for Depression . Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique that modulates cortical excitability. In repetitive TMS (rTMS), trains of several pulses are delivered through repeated stimulation over the same area with frequencies ranging from 1 to 20 Hz.
Orthotic Devices and Shoes - Cigna
static.cigna.comI. Cranial Orthosis Coding for Cranial Orthoses • A custom molded/fitted cranial orthotic device (HCPCS code S1040) is considered medically necessary for the treatment of synostotic plagiocephaly (i.e., craniosynostosis) following surgical correction when the benefit plan includes coverage for this indication.
Related documents
Non-Alcoholic Fatty Liver Disease: A Patient’s Guide
www.hepatitis.va.govFatty liver (steatosis) occurs when the liver has more than 5 -10% of its weight in fat. NAFLD is related to obesity, diabetes and often abnormal levels of fat in the blood and high blood pressure. Fatty liver in isolation does not damage the liver, however nonalcoholic steatohepatitis (NASH) which is
The Diagnosis and Management of Nonalcoholic Fatty Liver ...
aasldv2019stg.aasld.orgThe prevalence of NASH among NAFLD patients who had liver biopsy for a “clinical indication” is estimated to be 59.10% (95% CI, 47.55-69.73).(16) TABLE 2. NAFLD and Related Definitions NAFLD Encompasses the entire spectrum of FLD in individuals without significant alcohol consumption, ranging from fatty liver to SH to cirrhosis
NAFLD/NASHの最近の動向 - NCGM
www.kanen.ncgm.go.jpnafld/nashの最近の動向 愛知医科大学内科学講座 （肝胆膵内科） 米田 政志. 2020年1月24日、東京 令和元年度第2回都道府県肝疾患診療連携拠点病院
2019 年5月 日本超音波医学会 用語・診断基準委員会
www.jsum.or.jpNAFLDの中には肝硬変 や肝癌に至ることのある進行性の一群があることが明らかにされ、これらは non-alcoholic steatohepatitis（NASH）と呼ばれ、比較的良性の経過をたどる ことの多いnonalcoholic fatty liver (NAFL)とは区別して分類されている1,2,3)。
NAFLD/NASH診療戦略2020 ～ガイドラインからパイプライ …
asunorinsho.aichi-hkn.jp非アルコール性脂肪性肝疾患 （Nonalcoholic fatty liver disease: NAFLD）の10-20%程 度 に非アルコール性脂肪肝炎（Nonalcoholic steatohepatitis: NASH）が存在し、NASHの一部の 症例が肝硬変、肝細胞癌（ HCC） へ至る。一方、 NAFLDの死因は心血管イベント、他臓器癌、肝
特にNAFLD/NASHについて
hospital.tottori.tottori.jpnafld/nashは生命予後に影響するか？ nafld/nash診療ガイドライン2014 より引用 nafld/nashは一般住民より生存率が低率である。 nafldの死因に関しては、 ①心血管イベント、 ②悪性疾患、 ③肝疾患、の順で多い。 nashはにおいて心血管イベン
非アルコール性脂肪肝(NAFLD) nonalcoholic fatty liver …
sakamoto-cl.jp非アルコール性脂肪肝(NAFLD) Non-Alcoholic Fatty Liver Disease 単純性脂肪肝simple fatty liver 非アルコール性脂肪性肝炎(NASH) nonalcoholic steatohepatitis NASH 患者数は100万人とも200万人とも言われる・・・